This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The GLP-1 drug Wegovy tops the list of medications expected to be included in the next round of Medicare price negotiations, according to a paper in the Journal of Managed Care & SpecialtyPharmacy. Last month, Medicare officials unveiled prices for the first 10 drugs chosen for negotiation.
21, 2022) – Amber SpecialtyPharmacy announces that it will begin dispensing TZIELD (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D. Read more about the pharmacy’s infusion service offerings here. OMAHA, Neb.
By Max Kopp Diabetes care is entering a new era—yet even in 2025, continuous glucose monitors (CGMs) remain out of reach for millions. Despite a decade of innovation, current CGMs often fail to meet the needs of everyday people with type 2 diabetes, particularly those in under-resourced or underserved communities.
Orsini SpecialtyPharmacy, a leading independent specialtypharmacy focused on rare diseases and gene therapies, has been selected by Provention Bio, Inc. as a specialtypharmacy for TZIELD ® (teplizumab).
HSSPs improve medication adherence and reduce total health care costs by directly managing medications for complex chronic conditions like cancer, diabetes, COPD and CHF.
A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialtypharmacies, copay program vendors, patient assistance programs, nurses, etc. About the author.
And so I did internships during school in managed care pharmacy, I did coming out of pharmacy school a residency a managed care pharmacy where you’re really rotating through learning about all sorts of different areas within the health plan. During the residency I got a lot of good experience there.
In an interview with Pharmacy Times ®, Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, remote monitoring program coordinator and endocrinology clinical pharmacy specialist at the Cleveland Clinic, shares insights about the upcoming American Diabetes Association 85th Scientific Sessions.
It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans. The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target.
Ready-to-use glucagon has made a transformative impact for individuals with diabetes. Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage.
Formulary Strategies have several flavors, which generally include: covered or not covered, tiering, quantity limits, prior authorization requirements, step therapy requirements and pharmacy network restrictions (specialtypharmacy only/limited distribution).
Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D) in an interview with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois. The 3 largest PBMs now cover CGM for anybody with diabetes.
Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & SpecialtyPharmacy, 27(7), 903-907. Casalino, L.,
He emphasizes the importance of staying updated on medical advancements through state pharmacy associations, digital health platforms, and engaging with students and residents. Pharmacy Times: What aspects of the ADA 2025 Scientific Sessions do you think will be most relevant to patients managing diabetes in a community pharmacy setting?
SHOW MORE A groundbreaking trial shows zimislecel significantly reduces insulin dependence in type 1 diabetes patients, offering hope for a functional cure. 1,2 Image credit: Davizro Photography | stock.adobe.com Zimislecel works by restoring the pancreas’ ability to produce insulin and helping individuals regulate blood sugar levels.
SHOW MORE New research reveals a significant link between type 2 diabetes, obesity, and fatty liver disease. Emerging study findings from investigators at Linköping University discovered that 6 out of 10 individuals with type 2 diabetes (T2D) had fatty liver.
Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role. The position ensures continuous care coordination and medication oversight across the system’s specialtypharmacy and neurology practices. 1 Evidence from recent studies supports the effectiveness of this approach.
The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. However, we urge CMS to consider broadening eligibility criteria to include individuals who are overweight but have not yet developed these conditions. 14 National Health Council.
The dual-target approach of amylin and GLP-1 receptor agonists offers a promising strategy for managing obesity and type 2 diabetes. SHOW MORE CagriSema shows promising weight loss and metabolic benefits in recent trials, offering new hope for obesity and type 2 diabetes management.
Sharing insights from the American Diabetes Association 85th Scientific Sessions, she emphasizes the potential of new technologies like continuous glucose monitoring sensors for early diabetes detection and prevention, sharing a personal example of a student who discovered his diabetes through such technology.
Kevin Sayer, CEO of Dexcom, sat down with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, to discuss how continuous glucose monitors (CGMs) offer patients with type 2 diabetes (T2D) a comprehensive "scoreboard" of their health.
Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC, director at Pericardial Disease Center and professor of medicine, and Sean Krohn, PharmD, CSP, MSCS, lead clinical pharmacist, specialtypharmacy, focused on rilonacept's mechanism of action in treating recurrent pericarditis.
SHOW MORE Low-energy total diet replacement programs show promise for individuals with obesity and type 2 diabetes, without increasing eating disorder risks. Participants followed a 12-week TDR program with behavioral support, showing non-inferiority in eating disorder symptoms compared to usual care.
Goldman and Isaacs discussed the significant barriers to glucagon prescription and utilization for individuals with diabetes. Goldman and Isaacs discussed the significant barriers to glucagon prescription and utilization for individuals with diabetes.
Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC, director at Pericardial Disease Center and professor of medicine, and Sean Krohn, PharmD, CSP, MSCS, lead clinical pharmacist, specialtypharmacy, discussed a complex case of severe pericarditis in an elderly patient who could not tolerate traditional treatments like NSAIDs or colchicine.
They are also more likely to have diabetes, pain, and disability than other groups. 11 STEPPING UP A LEVEL Pharmacy teams can also speak to and for their communities. Improving cultural humility in pharmacy education: a focus on diabetes management during religious fasting. Pharmacotherapy. 2007;27(7):1062-1079.
For example, CPAs are especially impactful in managing chronic conditions such as diabetes, heart failure, and rheumatoid arthritis, where pharmacist intervention has been shown to improve outcomes and reduce hospitalizations. Creating disease-specific competency assessments also ensures alignment with evolving standards of care.
4 Nononcology applications are growing, however, particularly for conditions such as osteoarthritis, type 1 diabetes, and Parkinson disease. CD19-directed CAR T therapy has shown promising outcomes in systemic lupus erythematosus, prompting more than a dozen trials targeting lupus, type 1 diabetes, myasthenia gravis, and multiple sclerosis.
link] Download Issue PDF Download RIS Articles in this issue Correct Patient Misconceptions Around Biosimilars Condition Watch: Diabetes Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School Pharmacists Can Provide Travel Health Tips for Patients Is Fluoride Friend or Foe? Biosimilars Council. September 2024.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content